BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9727405)

  • 1. Analysis of immune deviation elicited by antigens injected into the subretinal space.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts.
    Jiang LQ; Jorquera M; Streilein JW
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3347-54. PubMed ID: 8225870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune privilege extended to allogeneic tumor cells in the vitreous cavity.
    Jiang LQ; Streilein JW
    Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):224-8. PubMed ID: 1987103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous cavity-associated immune deviation induced by retinal S antigen.
    Li Z; Peng G; Li C
    Yan Ke Xue Bao; 2001 Sep; 17(3):144-7, 172. PubMed ID: 12567740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen.
    Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antigen-bearing eye and the spleen are indispensable in maintaining anterior chamber-associated immune deviation.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):534-9. PubMed ID: 9040487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants.
    Grisanti S; Ishioka M; Kosiewicz M; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1619-26. PubMed ID: 9224290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic privilege evoked by histoincompatible intracameral retinal transplants.
    Jiang LQ; Streilein JW
    Reg Immunol; 1990-1991; 3(3):121-30. PubMed ID: 2098067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
    Kawashima H; Yamagami S; Tsuru T; Gregerson DS
    Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation.
    Sonoda KH; Sakamoto T; Qiao H; Hisatomi T; Oshima T; Tsutsumi-Miyahara C; Exley M; Balk SP; Taniguchi M; Ishibashi T
    Immunology; 2005 Nov; 116(3):390-9. PubMed ID: 16236129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of immune privilege in eyes with Mycobacteria tuberculosa adjuvant-induced uveitis.
    Mo JS; Streilein JW
    Ocul Immunol Inflamm; 2005; 13(2-3):139-47. PubMed ID: 16019673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K; Wiggert B; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gammadelta T cells in anterior chamber-induced tolerance in CD8(+) CTL responses.
    Xu Y; Kapp JA
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3473-9. PubMed ID: 12407158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior chamber-associated immune deviation induced by soluble antigens.
    Mizuno K; Clark AF; Streilein JW
    Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1112-9. PubMed ID: 2732026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation.
    Jiang L; Yang P; He H; Li B; Lin X; Hou S; Zhou H; Huang X; Aize K
    Mol Vis; 2007 Jun; 13():968-74. PubMed ID: 17653037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior chamber-associated immune deviation elicited via primate eyes.
    Eichhorn M; Horneber M; Streilein JW; Lutjen-Drecoll E
    Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):2926-30. PubMed ID: 8360025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.